189 related articles for article (PubMed ID: 26040280)
1. CD24(+) cells fuel rapid tumor growth and display high metastatic capacity.
Rostoker R; Abelson S; Genkin I; Ben-Shmuel S; Sachidanandam R; Scheinman EJ; Bitton-Worms K; Orr ZS; Caspi A; Tzukerman M; LeRoith D
Breast Cancer Res; 2015 Jun; 17(1):78. PubMed ID: 26040280
[TBL] [Abstract][Full Text] [Related]
2. CD24 cell surface expression in Mvt1 mammary cancer cells serves as a biomarker for sensitivity to anti-IGF1R therapy.
Rostoker R; Ben-Shmuel S; Rashed R; Shen Orr Z; LeRoith D
Breast Cancer Res; 2016 May; 18(1):51. PubMed ID: 27179633
[TBL] [Abstract][Full Text] [Related]
3. CD44(+)/CD24(-/low) cancer stem/progenitor cells are more abundant in triple-negative invasive breast carcinoma phenotype and are associated with poor outcome.
Idowu MO; Kmieciak M; Dumur C; Burton RS; Grimes MM; Powers CN; Manjili MH
Hum Pathol; 2012 Mar; 43(3):364-73. PubMed ID: 21835433
[TBL] [Abstract][Full Text] [Related]
4. Differential in vivo tumorigenicity of distinct subpopulations from a luminal-like breast cancer xenograft.
Skrbo N; Hjortland GO; Kristian A; Holm R; Nord S; Prasmickaite L; Engebraaten O; Mælandsmo GM; Sørlie T; Andersen K
PLoS One; 2014; 9(11):e113278. PubMed ID: 25419568
[TBL] [Abstract][Full Text] [Related]
5. Metalloprotease-disintegrin ADAM12 actively promotes the stem cell-like phenotype in claudin-low breast cancer.
Duhachek-Muggy S; Qi Y; Wise R; Alyahya L; Li H; Hodge J; Zolkiewska A
Mol Cancer; 2017 Feb; 16(1):32. PubMed ID: 28148288
[TBL] [Abstract][Full Text] [Related]
6. Phenotypic characterization of mammosphere-forming cells from the human MA-11 breast carcinoma cell line.
Rappa G; Lorico A
Exp Cell Res; 2010 May; 316(9):1576-86. PubMed ID: 20074564
[TBL] [Abstract][Full Text] [Related]
7. Breast cancer stem cells expressing different stem cell markers exhibit distinct biological characteristics.
Shao J; Fan W; Ma B; Wu Y
Mol Med Rep; 2016 Dec; 14(6):4991-4998. PubMed ID: 27840965
[TBL] [Abstract][Full Text] [Related]
8. Characterizing the HER2/neu status and metastatic potential of breast cancer stem/progenitor cells.
Pommier SJ; Quan GG; Christante D; Muller P; Newell AE; Olson SB; Diggs B; Muldoon L; Neuwelt E; Pommier RF
Ann Surg Oncol; 2010 Feb; 17(2):613-23. PubMed ID: 19838757
[TBL] [Abstract][Full Text] [Related]
9. Proteolysis-a characteristic of tumor-initiating cells in murine metastatic breast cancer.
Hillebrand LE; Bengsch F; Hochrein J; Hülsdünker J; Bender J; Follo M; Busch H; Boerries M; Reinheckel T
Oncotarget; 2016 Sep; 7(36):58244-58260. PubMed ID: 27542270
[TBL] [Abstract][Full Text] [Related]
10. Highly specific role of the insulin receptor in breast cancer progression.
Rostoker R; Abelson S; Bitton-Worms K; Genkin I; Ben-Shmuel S; Dakwar M; Orr ZS; Caspi A; Tzukerman M; LeRoith D
Endocr Relat Cancer; 2015 Apr; 22(2):145-57. PubMed ID: 25694511
[TBL] [Abstract][Full Text] [Related]
11. Primary breast tumor-derived cellular models: characterization of tumorigenic, metastatic, and cancer-associated fibroblasts in dissociated tumor (DT) cultures.
Drews-Elger K; Brinkman JA; Miller P; Shah SH; Harrell JC; da Silva TG; Ao Z; Schlater A; Azzam DJ; Diehl K; Thomas D; Slingerland JM; Perou CM; Lippman ME; El-Ashry D
Breast Cancer Res Treat; 2014 Apr; 144(3):503-17. PubMed ID: 24567196
[TBL] [Abstract][Full Text] [Related]
12. Characteristic genes in luminal subtype breast tumors with CD44+CD24-/low gene expression signature.
Tsunoda Y; Sakamoto M; Sawada T; Sasaki A; Yamamoto G; Tachikawa T
Oncology; 2011; 81(5-6):336-44. PubMed ID: 22237177
[TBL] [Abstract][Full Text] [Related]
13. Features of CD44+/CD24-low phenotypic cell distribution in relation to predictive markers and molecular subtypes of invasive ductal carcinoma of the breast.
Gudadze M; Kankava Q; Mariamidze A; Burkadze G
Georgian Med News; 2014 Mar; (228):81-7. PubMed ID: 24743129
[TBL] [Abstract][Full Text] [Related]
14. ALDH/CD44 identifies uniquely tumorigenic cancer stem cells in salivary gland mucoepidermoid carcinomas.
Adams A; Warner K; Pearson AT; Zhang Z; Kim HS; Mochizuki D; Basura G; Helman J; Mantesso A; Castilho RM; Wicha MS; Nör JE
Oncotarget; 2015 Sep; 6(29):26633-50. PubMed ID: 26449187
[TBL] [Abstract][Full Text] [Related]
15. Breast cancer stem cell markers CD44, CD24 and ALDH1: expression distribution within intrinsic molecular subtype.
Ricardo S; Vieira AF; Gerhard R; Leitão D; Pinto R; Cameselle-Teijeiro JF; Milanezi F; Schmitt F; Paredes J
J Clin Pathol; 2011 Nov; 64(11):937-46. PubMed ID: 21680574
[TBL] [Abstract][Full Text] [Related]
16. CD44+/CD24- breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasis.
Sheridan C; Kishimoto H; Fuchs RK; Mehrotra S; Bhat-Nakshatri P; Turner CH; Goulet R; Badve S; Nakshatri H
Breast Cancer Res; 2006; 8(5):R59. PubMed ID: 17062128
[TBL] [Abstract][Full Text] [Related]
17. Differential characteristics of heart, liver, and brain metastatic subsets of murine breast carcinoma.
Erin N; Kale S; Tanrıöver G; Köksoy S; Duymuş O; Korcum AF
Breast Cancer Res Treat; 2013 Jun; 139(3):677-89. PubMed ID: 23760857
[TBL] [Abstract][Full Text] [Related]
18. Introduction of SV40ER and hTERT into mammospheres generates breast cancer cells with stem cell properties.
Paranjape AN; Mandal T; Mukherjee G; Kumar MV; Sengupta K; Rangarajan A
Oncogene; 2012 Apr; 31(15):1896-909. PubMed ID: 21874052
[TBL] [Abstract][Full Text] [Related]
19. Numb protein expression correlates with a basal-like phenotype and cancer stem cell markers in primary breast cancer.
Rennstam K; McMichael N; Berglund P; Honeth G; Hegardt C; Rydén L; Luts L; Bendahl PO; Hedenfalk I
Breast Cancer Res Treat; 2010 Jul; 122(2):315-24. PubMed ID: 19795205
[TBL] [Abstract][Full Text] [Related]
20. [Analysis on clone in vitro and tumorigenic capacity in vivo of different subsets cells from the MCF-7 human breast cancer cell line].
Li Z; Liu CP; He YL; Tian Y; Huang T
Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Jul; 39(4):547-9. PubMed ID: 18798490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
